Medication related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab- a review

The link between medication related osteonecrosis of the jaw (MRONJ) and bone modulating therapies such as bisphosphonates and denosumab is well established and the number of reported cases is increasing. The development of novel medications in cancer therapy, autoimmune and bone conditions has led to further cases of MRONJ being reported. However, in addition to this group of medications there are increasingly new agents in cancer therapy, such as anti-angiogenics agents that have now also been implicated in the development of MRONJ.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2zE1DfC